These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2531230)

  • 1. Anti-laminin receptor antibody targeting of liposomes with encapsulated doxorubicin to human breast cancer cells in vitro.
    Rahman A; Panneerselvam M; Guirguis R; Castronovo V; Sobel ME; Abraham K; Daddona PE; Liotta LA
    J Natl Cancer Inst; 1989 Dec; 81(23):1794-800. PubMed ID: 2531230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites.
    Liotta LA; Horan Hand P; Rao CN; Bryant G; Barsky SH; Schlom J
    Exp Cell Res; 1985 Jan; 156(1):117-26. PubMed ID: 2578109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.
    Suzuki S; Uno S; Fukuda Y; Aoki Y; Masuko T; Hashimoto Y
    Br J Cancer; 1995 Sep; 72(3):663-8. PubMed ID: 7669578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody.
    Hand PH; Thor A; Schlom J; Rao CN; Liotta L
    Cancer Res; 1985 Jun; 45(6):2713-9. PubMed ID: 3157447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets.
    Tandon NN; Holland EA; Kralisz U; Kleinman HK; Robey FA; Jamieson GA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):535-42. PubMed ID: 1826081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
    Salkho NM; Paul V; Kawak P; Vitor RF; Martins AM; Al Sayah M; Husseini GA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):462-472. PubMed ID: 29644867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
    Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
    Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S; Igarashi S; Honda A; Sato S; Hanai N
    Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro.
    Ahmad I; Allen TM
    Cancer Res; 1992 Sep; 52(17):4817-20. PubMed ID: 1511445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
    J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy.
    Castronovo V; Colin C; Claysmith AP; Chen PH; Lifrange E; Lambotte R; Krutzsch H; Liotta LA; Sobel ME
    Am J Pathol; 1990 Dec; 137(6):1373-81. PubMed ID: 2148054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
    Castronovo V; Taraboletti G; Liotta LA; Sobel ME
    J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.